UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048220
Receipt number R000054950
Scientific Title Randomized Controlled Clinical Trial on Lateral Invagination of the Colorectal Anastomosis by Double Stapling
Date of disclosure of the study information 2022/07/01
Last modified on 2022/07/01 12:33:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized Controlled Clinical Trial on Lateral Invagination of the Colorectal Anastomosis by Double Stapling

Acronym

ILAC Trial

Scientific Title

Randomized Controlled Clinical Trial on Lateral Invagination of the Colorectal Anastomosis by Double Stapling

Scientific Title:Acronym

ILAC Trial

Region

Japan Europe


Condition

Condition

Colorectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the double staple colorectal anastomosis lateral invagination technique reduces the incidence of suture dehiscence compared to the conventional anastomotic technique.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluate the rate of anastomotic dehiscence diagnosed in the first 30 postoperative days.

Key secondary outcomes

1. Duration of surgery (min)
2. Perioperative morbidity (TF: 30 and 90 days postoperative, or in hospital) using the Clavien-
Dindo classification.
3. Perioperative mortality (TF: 30 and 90 days postoperative, or in hospital)
4. Hospital stay.
5. Hospital readmissions
6. Surgical reinterventions
7. Stoma-free survival 1 year after surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Anastomosis with double stapling technique

Interventions/Control_2

Anastomosis with lateral invagination technique

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

- Age> 18 years
- Indication of resection of the left colon, sigmoid or upper rectum
- Minimally invasive approach
- Open surgery approach
- Double staple colorectal anastomosis
- Signed informed consent for inclusion in the study

Key exclusion criteria

- Patients <18 years
- Pregnancy
- ASA> III
- Absolute contraindication for anesthesia
- Patients who receive more than 1 gastrointestinal anastomosis during the same procedure
- Planned multi-organ resection during the same procedure
- Urgent / emergent surgery
- Reinforced anastomosis after positive intraoperative leak test
- Patients with simultaneous application of debulking and HIPEC
- Crohn's disease or active ulcerative colitis

Target sample size

786


Research contact person

Name of lead principal investigator

1st name Antonio
Middle name M
Last name Lacy

Organization

HOSPITAL CLINIC DE BARCELONA

Division name

GASTROINTESTINAL SURGERY DEPARTMENT

Zip code

08036

Address

Carrer de Villarroel, 170 08036 Barcelona, Spain

TEL

34932275402

Email

alacy@clinic.cat


Public contact

Name of contact person

1st name Carolina
Middle name
Last name Gonzalez

Organization

HOSPITAL CLINIC DE BARCELONA

Division name

GASTROINTESTINAL SURGERY DEPARTMENT

Zip code

08036

Address

Carrer de Villarroel, 170 08036 Barcelona, Spain

TEL

34932275402

Homepage URL


Email

carol.gonzaleza@gmail.com


Sponsor or person

Institute

HOSPITAL CLINIC DE BARCELONA

Institute

Department

Personal name



Funding Source

Organization

HOSPITAL CLINIC DE BARCELONA

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Comite de Etica de la Investigacion con medicamentos del Hospital Clinic de Barcelona

Address

Villarroel, 170-08036 Barcelona (Espana)

Tel

93 227 54 00

Email

dvargas@clinic.cat


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 11 Month 07 Day

Date of IRB

2020 Year 11 Month 23 Day

Anticipated trial start date

2020 Year 12 Month 01 Day

Last follow-up date

2023 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 07 Month 01 Day

Last modified on

2022 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054950


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name